Sentence examples for available highly active from inspiring English sources

Currently available highly active antiretroviral therapy (HAART) regimens are able to dramatically decrease plasma HIV RNA levels in the majority of patients with chronic HIV infection, leading to sustained increases in absolute CD4+ T cell counts and decreased risk of progression to AIDS and death.

On HepG2 cells, Db α EGFR-scTRAIL exerted an ∼10-fold increased bioactivity compared with scFv α EGFR-scTRAIL and a commercially available, highly active 'KillerTRAIL'.

Treatment of HIV infected patients with currently available highly active anti-retroviral (HAART) drugs though successful in reducing the burden of the disease but is associated with various side effects, including emergence of drug resistant HIV strains [ 2- 6].

One potential problem associated with anti-HIV therapy is the emergence of resistant mutants, which may ultimately render the currently available highly active antiretroviral therapy (HAART) ineffective [ 58– 60].

Estimates of the cost of treating HIV infection appeared soon after the availability of highly active antiretroviral therapy (ART) to prove cost efficacy of new drugs available in the late 1990s.

As PHS1 accepts both NPP and GPP substrates forming different monoterpenes, it was overexpressed in tomato fruits to test if NPP is also available in a tissue highly active in carotenoid production.

HIV-infected women should have WHO clinical staging, CD4 count if indicated and available, and initiation of highly active antiretroviral treatment (HAART) for women in stages III or IV, or in stages I and II if CD4 count <250.

Limited efficacy data are available, but controlled studies of highly active RRMS have shown significant efficacy of the treatment, as shown by a 60%70%% reduction in the relapse rate (compared with placebo or intravenous methylprednisolone) as well as reduced disability progression and MRI disease activity 52, 53.

Numbers needed to treat, to prevent 1 death, are 9 patients in a setting without highly active antiretroviral therapy (HAART) available and 22 patients with HAART available.

Here we have exploited this oncogenic defect to design a synthetic promoter, CTP1, that, in contrast to currently available tumor-selective promoters, is both highly active in cancer cells and highly cancer-cell-specific. CTP1 directs high-level β-galactosidase expression in freshly isolated biopsies of secondary colon cancer, but is not detectably active in associated normal liver tissue.

Oncologists should remain attentive of this problem as more highly active regimes become available.